Delivery Order SPE2DB25D7067-SPE2DB25FSWAX
- Not listed
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,053.39, is for the supply of 4,564,287,862 units of Misoprostol 200 MCG Tablet. The contract is a firm fixed-price, no set-aside delivery order with a completion date of April 16, 2024. Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, has a significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mifepristone 300 mg tablets in a 28-day supply quantity, with a ceiling value of $84,653.44. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.79 to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 50-0.2 mg tablets (60-count) on August 6, 2025, with completion scheduled for August 7, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,219.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 75-0.2 mg tablets (60-count) on May 30, 2025, with a completion date of June 2, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be fulfilled from the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,272.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 50-0.2 mg tablets (60-count units) on July 31, 2025, with completion scheduled for August 1, 2025. This award was not designated as a set-aside contract and represents a routine pharmaceutical procurement through the federal medical supply chain. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of mifepristone 300 mg tablets, a medication used for certain medical purposes. The contract has a ceiling value of $81,104.15 and is a firm-fixed-price contract. The contract is not set-aside and is therefore open to full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on August 18, 2025, for an amount of $39,640.32 under a firm fixed-price contract. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract is scheduled for completion by August 19, 2025,...
- The Defense Logistics Agency awarded a delivery order valued at $8,705.51 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Carboprost 250 micrograms per milliliter in vial format. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 5, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSWAXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Misoprostol 100 microgram tablets in unit dose packaging of 100 units. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,319.56 and is scheduled for completion by September 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for the Defense Logistics Agency's medical supply chain, delivering pharmaceuticals and medical supplies to support military healthcare systems. The company's role as a prime vendor under the Pharmaceutical Prime Vendor Global Program enables it to supply a comprehensive range of medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order required no set-aside designation, indicating the award was made through open competition consistent with AmerisourceBergen's broader federal procurement portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/16/25 |